HK:0874 Stock Latest News
Company AnnouncementsBaiyunshan Pharmaceutical Sees Profit Slump Despite Steady Revenue in Q3 20264d ago
Company AnnouncementsGuangzhou Baiyunshan Sets Board Meeting to Approve Nine-Month Results2w ago
Company AnnouncementsGuangzhou Baiyunshan Affirms Compliance on Related Party Disclosures in 2025 Report1M ago
Company AnnouncementsBaiyunshan Shareholders Approve All Resolutions at 2026 Extraordinary Meeting2M ago
Company AnnouncementsBaiyunshan’s GP Corp Aggregates Receivables Sales Into Disclosable HKEX Deal2M ago
Company AnnouncementsBaiyunshan Pharma Sets Mid-2026 Dividend in Unaudited Interim Report2M agoCompany AnnouncementsGuangzhou Baiyunshan Declares 2026 Interim Dividend and Sets H Share Record Date2M ago
Company AnnouncementsGuangzhou Baiyunshan Pharma Announces 2026 Interim Dividend and Tax Treatment Details2M ago
Company AnnouncementsGuangzhou Baiyunshan Schedules Board Meeting to Review 2026 Interim Results2M ago- Company AnnouncementsGuangzhou Baiyunshan Pharma Calls August 2026 EGM to Vote on Board Pay2M ago
Company AnnouncementsBaiyunshan Unit Weighs Capital Raise to Bring In Strategic Investors3M ago
Company AnnouncementsBaiyunshan Pharma Sets Out Board Line-up and Committee Roles5M ago
Company AnnouncementsGuangzhou Baiyunshan Sets Final 2025 Dividend and Tax Terms for H-Share Investors5M agoCompany AnnouncementsGuangzhou Baiyunshan Shareholders Approve All AGM Resolutions and Board Changes5M ago
Company AnnouncementsGuangzhou Baiyunshan Unit Sells RMB1 Billion in Receivables in Ongoing Securitisation Drive5M ago
Company AnnouncementsGuangzhou Baiyunshan Appoints Liu Hong as Employee Representative Director to New Board5M ago- Company AnnouncementsGuangzhou Baiyunshan Pharma Sets Vote on New Three-Year Board Line-Up5M ago
Company AnnouncementsGuangzhou Baiyunshan Sets 2025 AGM to Vote on Profit Distribution and Director Pay5M ago
Company AnnouncementsBaiyunshan Q1 Revenue Rises as Profit Margins Narrow and Cash Outflows Ease6M ago
Company AnnouncementsGuangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results6M ago
Company AnnouncementsGuangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share7M ago